Feras Hantash

Quest Diagnostics (United States)

Papers

1

Total Citations

6

H-Index

1

About

Feras Hantash is a geneticist whose research focuses on molecular diagnostics and population genetics, with a particular emphasis on inherited disorders prevalent in the Ashkenazi Jewish community. His most notable contribution is the development of a rapid, one-step carrier detection assay for mucolipidosis IV (MLIV) mutations, a severe neurodegenerative lysosomal storage disorder. Published in 2006, this work has garnered 6 citations, reflecting its practical utility in streamlining genetic screening protocols. By enabling efficient and accurate identification of carriers, Hantash’s assay has enhanced prenatal and preconception testing, reducing the burden of MLIV in at-risk populations. His research underscores the importance of targeted, cost-effective diagnostic tools in public health genetics, bridging the gap between laboratory innovation and clinical application. Hantash’s work exemplifies how focused genetic assays can empower communities to make informed reproductive choices, highlighting his role in advancing precision medicine for rare diseases.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Rapid One-Step Carrier Detection Assay of Mucolipidosis IV Mutations in the Ashkenazi Jewish Population
6 citations · 2006
📈 Most Prolific Year: 2006 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Quest Diagnostics (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago